Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin A Palmitate in AMD with Delayed Dark Adaptation
NCT03478865Phase 1Completed
- Sponsor
- National Eye Institute
- Start
- Apr 2018
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of retinyl palmitate in age-related macular degeneration (AMD) (2 cohorts), sponsored by National Eye Institute. Primary endpoint: Rod Intercept Time at 1 month. Started Apr 2018; status: completed.
02
Drugs
retinyl palmitate
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT03478865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478865.